Literature DB >> 194110

Arginine-rich cationic proteins of human eosinophil granules: comparison of the constituents of eosinophilic and neutrophilic leukocytes.

I Olsson, P Venge, J K Spitznagel, R I Lehrer.   

Abstract

Several arginine-rich cationic proteins previously isolated from granules of leukemic myeloid cells have been found to reside primarily in human eosinophil leukocytes. The major component has a molecular weight of 21,000 and it contains approximately 2.6 moles of zinc per mole of protein. Velocity centrifugation of cytoplasm from leukocytes of patients with marked eosinophilia showed that this group of proteins is packaged in the crystalloid-containing large eosinophil granules. Approximately 30% of the protein content of eosinophil granules belonged to this group of cationic proteins. Bactericidal or esterolytic activities of the cationic proteins were not detected, nor did they inhibit guinea pig anaphylatoxin or histamine-induced contraction. The basic protein previously demonstrated in guinea pig eosinophils may be analogous to the group of basic proteins of human eosinophils but great differences are found for molecular weight and amino acid composition.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194110

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  33 in total

Review 1.  What is the role of the eosinophil?

Authors:  P Venge
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

2.  Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.

Authors:  C G Peterson; P Venge
Journal:  Biochem J       Date:  1987-08-01       Impact factor: 3.857

Review 3.  Eosinophils, ribonucleases and host defense: solving the puzzle.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

4.  Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Authors:  Y Raab; K Fredens; B Gerdin; R Hällgren
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

5.  Pharmacological control of human basophil histamine release stimulated by eosinophil granule major basic protein.

Authors:  L L Thomas; L M Zheutlin; G J Gleich
Journal:  Immunology       Date:  1989-04       Impact factor: 7.397

6.  Dissociation of separate mechanisms of estrogen action by actinomycin D.

Authors:  A N Tchernitchin; P Galand
Journal:  Experientia       Date:  1982-04-15

7.  Identification of a serum-derived promotor of granulocyte granule secretion: study on a patient with chronic pruritus.

Authors:  P Venge; M Boberg; L Håkansson; C Peterson
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

8.  Eosinophil cationic protein in inflammatory synovial effusions as evidence of eosinophil involvement.

Authors:  R Hällgren; A Bjelle; P Venge
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

9.  Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.

Authors:  R Hällgren; B Gudbjörnsson; E Larsson; K Fredens
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

10.  Purification and characterization of a new cationic protein--eosinophil protein-X (EPX)--from granules of human eosinophils.

Authors:  C G Peterson; P Venge
Journal:  Immunology       Date:  1983-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.